Literature DB >> 22266130

Ways and means of eukaryotic mRNA decay.

Vidya Balagopal1, Lydia Fluch, Tracy Nissan.   

Abstract

Messenger RNA degradation is an important point of control for gene expression. Genome-wide studies on mRNA stability have demonstrated its importance in adaptation and stress response. Most of the key players in mRNA decay appear to have been identified. The study of these proteins brings insight into the mechanism of general and specific targeting of transcripts for degradation. Recruitment and assembly of mRNP complexes enhance and bring specificity to mRNA decay. mRNP complexes can form larger structures that have been found to be ubiquitous in nature. Discovery of P-Bodies, an archetype of this sort of aggregates, has generated interest in the question of where mRNA degrades. This is currently an open question under extensive investigation. This review will discuss in detail the recent developments in the regulation of mRNA decay focusing on yeast as a model system. This article is part of a Special Issue entitled: Nuclear Transport and RNA Processing.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266130     DOI: 10.1016/j.bbagrm.2012.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  Exonuclease hDIS3L2 specifies an exosome-independent 3'-5' degradation pathway of human cytoplasmic mRNA.

Authors:  Michal Lubas; Christian K Damgaard; Rafal Tomecki; Dominik Cysewski; Torben Heick Jensen; Andrzej Dziembowski
Journal:  EMBO J       Date:  2013-06-11       Impact factor: 11.598

2.  The cytoplasmic mRNA degradation factor Pat1 is required for rRNA processing.

Authors:  Mridula Muppavarapu; Susanne Huch; Tracy Nissan
Journal:  RNA Biol       Date:  2016-02-26       Impact factor: 4.652

Review 3.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

4.  The oocyte-to-embryo transition in mouse: past, present, and future.

Authors:  Richard M Schultz; Paula Stein; Petr Svoboda
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

5.  p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements.

Authors:  Sanaz Derech-Haim; Yael Friedman; Amnon Hizi; Mary Bakhanashvili
Journal:  J Mol Med (Berl)       Date:  2020-02-04       Impact factor: 4.599

Review 6.  Methods for the analysis of transcriptome dynamics.

Authors:  Daniela F Rodrigues; Vera M Costa; Ricardo Silvestre; Maria L Bastos; Félix Carvalho
Journal:  Toxicol Res (Camb)       Date:  2019-07-26       Impact factor: 3.524

7.  Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs.

Authors:  Fei Zhou; Yanru Wang; Hongliang Liu; Neal Ready; Younghun Han; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeböller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria Teresa Landi; Irene Brüske; Angela Risch; Yuanqing Ye; Xifeng Wu; David C Christiani; Gary Goodman; Chu Chen; Christopher I Amos; Qingyi Wei
Journal:  Mol Carcinog       Date:  2016-11-15       Impact factor: 4.784

Review 8.  RNA-binding proteins in neurodegeneration: Seq and you shall receive.

Authors:  Julia K Nussbacher; Ranjan Batra; Clotilde Lagier-Tourenne; Gene W Yeo
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

Review 9.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

10.  The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway.

Authors:  Michal Malecki; Sandra C Viegas; Tiago Carneiro; Pawel Golik; Clémentine Dressaire; Miguel G Ferreira; Cecília M Arraiano
Journal:  EMBO J       Date:  2013-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.